3645 results for «447»

Filter By

3645 results

Renal denervation in the real-world: performance in high risk subgroups

05 Oct 2021 – From AICT-AsiaPCR 2021

After having evoked in particular the SPRAL HTN Global Clinical Program, the RDN consensus statements, the EHS position paper 2021, the ARDeC, and the STEP Trial, Tzung-Dau Wang shares his experience in using renal denervation to manage uncontrolled hypertension by illustrating his words with the case...

Renal denervation in

Putting evidence in clinical practice of managing high-bleeding risk (HBR) patients

06 Oct 2021 – From AICT-AsiaPCR 2021

In this video, Aaron Wong and Paul Ong share their views on the contribution of various stents to the treatment of HBR patients and the value of durable, biodegradable, non-polymer stents in specific cases. They base their discussion on the results of numerous studies on stents using...

Putting evidence in clinical practice of managing HBR patients

Cases and complications: coronary perforation

08 Oct 2021 – From AICT AsiaPCR 2021

Watch this session to learn more about various complications of coronary perforation and discover how to face them, thanks to a selection of challenging cases. 

Cases on complications of coronary perforation

IVUS-guided left main / left main bifurcation with Megatron

09 Oct 2021 – From AICT-AsiaPCR 2021

How to optimise outcome when treating complex lesions like left main? Watch this session to find out more about the new tools that can help! You will also learn how to overcome the complexities of left main / left main bifurcations with new technologies, and you will be proposed a...

IVUS-guided left main

OPTION – Indobufen or aspirin on top of clopidogrel after coronary drug-eluting stent implantation

08 Nov 2022

Ali Nazmi Calik provides his take on OPTION, which was presented during AHA 2022 in Chicago.

Ali Nazmi Calik

Author

Ali Nazmi Calik
OPTION – Indobufen or aspirin on top of clopidogrel after coronary drug-eluting stent implantation
Didn’t find what you were looking for?